Latest News

Cannabis stocks rise after Trump signs an order to ease restrictions on marijuana

Stocks of cannabis companies rose Thursday following a?U.S. The U.S. President Donald Trump signed an order to loosen federal regulations on marijuana, the largest shift in marijuana laws since 1970.

The decision to reclassify marijuana as a less harmful drug does not legalize it, but rather improves the operating environment for businesses by improving capital access, reducing taxes and accelerating research and development.

In afternoon trading, U.S. listed shares of Tilray rose over 6%. Aurora Cannabis?rose almost 9%. SNDL rose 6%. And Canopy Growth gained close to 12%.

According to senior administration officials, Trump's order "directs" his attorney general to move quickly with reclassifying marijuana. This could result in the psychoactive plant becoming listed along side common painkillers like ketamine, and testosterone as less dangerous drugs.

Irwin Simon said, "I don't believe that many shareholders would buy my stock or?a number of other cannabis shares" without rescheduling. This was before the order.

Reclassification would move marijuana from Schedule I (which includes substances such as heroin, ecstasy, and peyote) to Schedule III which covers substances that are associated with a moderate-to-low level of dependence.

According to reports, Trump is?considering an Medicare pilot program which would give some seniors access CBD.

Rearranging Medicare coverage and attracting investments from other investors and financial institutions would be likely to attract investment.

(source: Reuters)